Navigation Links
Bepotastine in Medical News

Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis

...hing associated with allergic conjunctivitis. bepotastine was approved in Japan for use as a systemic drug i...sian countries, to develop, manufacture and market bepotastine for ophthalmic use. In 2006, ISTA licensed the ex...an rights from Senju to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis. ...

ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis

...ons in the primary endpoints of ocular itching. As bepotastine is a new chemical entity in the U.S., ISTA expecte...hing associated with allergic conjunctivitis. bepotastine was approved in Japan for use as a systemic drug i...sian countries, to develop, manufacture and market bepotastine for ophthalmic use. In 2006, ISTA licensed the ex...

ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments

...- ISTA acquires exclusive North American rights to bepotastine for nasal allergy - ...rican rights to ophthalmic allergy applications of bepotastine and has been developing an ocular formulation of bepotastine to treat the symptoms of ocular itching that accom...
Bepotastine in Medical Technology

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting

... In another poster presentation titled "The Safety of the Anti-Histamine bepotastine Besilate Ophthalmic Solution in a Healthy Pediatric Population from Ten to .... The results were presented in the following poster presentations: bepotastine Besilate Ophthalmic Solution 1.0% Rapidly Reduces Conjunctival Hyperemia in...

ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration

...igns and symptoms of allergic conjunctivitis. bepotastine was approved in Japan for use as a systemic drug i...sian countries, to develop, manufacture and market bepotastine for ophthalmic use. In 2006, ISTA licensed the ex...an rights from Senju to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis. ...

ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing

...tive treatment against the signs and symptoms of allergic conjunctivitis. bepotastine was approved in Japan for use as a systemic drug in the treatment of allerg...rom Senju the exclusive North American rights to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis. About ISTA Pharmaceuticals ...

Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

... uncertainties related to ISTA's research and development programs (including without limitation the difficulty of predicting the timing or outcome of bepotastine product development efforts); the timing, scope, and outcome of FDA or other regulatory agency approval or actions; uncertainties and risks regarding ...

ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)

... uncertainties related to ISTA's research and development programs (including without limitation the difficulty of predicting the timing or outcome of bepotastine product development efforts); the timing, scope, and outcome of FDA or other regulatory agency approval or actions; uncertainties and risks regarding ...

ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine

...nalysis of its U.S. Phase II/III clinical study of bepotastine for the treatment of allergic conjunctivitis. The ...s of the study were the assessment of efficacy for bepotastine in treating ocular itching and redness. The prelim...on of the second primary endpoint, ocular redness, bepotastine showed a trend toward clinical significance, but d...
Bepotastine in Biological Technology

ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)

...e signs and symptoms of allergic conjunctivitis. bepotastine was approved in Japan for use as a systemic drug i...sian countries, to develop, manufacture and market bepotastine for ophthalmic use. In 2006, ISTA licensed the exc...an rights from Senju to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis. Ab...
Other Tags
(Date:7/2/2015)... PEACHTREE CITY, GA (PRWEB) , ... July 02, 2015 , ... ... introduce their newest innovation in compression socks designed for men. , For style ... compression socks into their daily routine. This is great news for men everywhere because ...
(Date:7/2/2015)... ... July 02, 2015 , ... When ... Coalition met for the late June Web-based session, the speakers discussed the importance ... and managing high-risk patients through coordinated care. , During the session, participants learned ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... and executing them with care and precision. There is an art and science ... had the honor of successfully reshaping the facial features and lives of more ...
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists at ... nearly $4 million through five federal grants to study a group of related ... deadly diseases. , The research will be conducted in the Regional Biocontainment ...
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3
(Date:6/23/2015)... 22, 2015 Research ... of the "Body-Worn Temperature Sensors Market - ... Forecast 2014 - 2020" report to their ... of the global body-worn temperature sensors market. The ... on the basis of types, care setting, patient ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
(Date:6/17/2015)... June 17, 2015  Crossmatch™, a leading provider ... its U.are.U ® 4500 fingerprint readers have ... Eateries, Inc., a San Jose, CA ... increase security, improve accountability and reduce fraud at ... non-repudiable identity confirmation for employee sign in and ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
Other Contents